Literature DB >> 27929662

Insulinoma Detection With MDCT: Is There a Role for Whole-Pancreas Perfusion?

Liang Zhu1, Huadan Xue1, Hao Sun1, Xuan Wang1, Wenming Wu2, Zhengyu Jin1, Yupei Zhao2.   

Abstract

OBJECTIVE: The purpose of this study is to investigate the role of whole-pancreas perfusion in detecting insulinomas with the use of MDCT.
MATERIALS AND METHODS: From January 2011 to December 2011, a total of 70 consecutive patients (33 men and 37 women; mean age, 46 years; range, 17-73 years) who underwent biphasic contrast-enhanced CT and whole-pancreas CT perfusion for suspected insulinomas were identified retrospectively. Patients were monitored for at least 3 years. Two radiologists who were blinded to the clinical and surgical data independently evaluated the images, first assessing only the biphasic contrast-enhanced CT images to detect tumor and assess diagnostic confidence on a 5-point scale. Next, perfusion parametric maps were evaluated and pancreatic perfusion parameters measured, and the presence of tumor was reidentified using a combination of the biphasic CT and perfusion image sets. A ROC curve was generated to compare the diagnostic accuracy of the two image sets.
RESULTS: The mean blood flow (BF) values of both the insulinomas and the insulinoma-harboring regions were statistically significantly higher (p < 0.01, for both) than the BF value of tumor-free pancreatic parenchyma. For the detection of insulinoma, biphasic CT had a sensitivity of 88.1%, a specificity of 85.7%, a positive predictive value of 91.1%, and a negative predictive value of 81.4%, whereas combined biphasic CT and perfusion had a sensitivity of 94.6%, a specificity of 94.7%, a positive predictive value of 96.7%, and a negative predictive value of 91.5%. The mean area under the ROC curve increased from 0.939 with biphasic CT to 0.999 with the addition of perfusion. Nine of 46 tumors (19.6%) for which findings were negative (n = 2) or indeterminate (n = 7) on biphasic CT were correctly diagnosed with the addition of perfusion.
CONCLUSION: The addition of pancreatic perfusion to biphasic contrast-enhanced CT may improve the detection of insulinomas.

Entities:  

Keywords:  MDCT; insulinoma; pancreatic imaging; perfusion

Mesh:

Year:  2016        PMID: 27929662     DOI: 10.2214/AJR.16.16351

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Homogenously isoattenuating insulinoma on biphasic contrast-enhanced computed tomography: Little benefits of diffusion-weighted imaging for lesion detection.

Authors:  Zhenshan Shi; Xiumei Li; Ruixiong You; Yueming Li; Xianying Zheng; Kamisha Ramen; Vikash Sahadeo Loosa; Dairong Cao; Qunlin Chen
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

Review 2.  Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Anupama Ramachandran; Kumble Seetharama Madhusudhan
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

3.  Application of spectral CT combined with perfusion scan in diagnosis of pancreatic neuroendocrine tumors.

Authors:  Yamin Wan; Hui Hao; Yunjin Chen; Yifan Zhang; Qingmei Yue; Zhizhen Li
Journal:  Insights Imaging       Date:  2022-09-04

4.  Diagnosis value preoperative localization of insulinoma by diffusion-weighted imaging: A pilot study.

Authors:  Li-Jun Chen; Yue-Dong Han; Ming Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.